Daily News Podcast

Bisphosphonate holiday reduces risk of atypical femur fracture

Publish date: October 10, 2018

 

A holiday from bisphosphonates may help reduce atypical femur fracture risk. Also today, most dermatologic drugs are safe for breastfeeding mothers, impressive HbA1c and weight control from a new novel drug, and short-term NSAIDs appear safe for high-risk patients.

Recommended Reading

PCV13 for older adults
MDedge Internal Medicine
Metabolic swings predict death, hold the antiplatelet, and more
MDedge Internal Medicine
Sexual assault, harassment linked to depression
MDedge Internal Medicine
Omadacycline equivalent to linezolid for skin infections
MDedge Internal Medicine
How to vaccinate patients on biologics
MDedge Internal Medicine
FDA approves new treatment for hereditary transthyretin-mediated amyloidosis
MDedge Internal Medicine
Allopurinol reduces risk of renal decline in gout patients
MDedge Internal Medicine
9-valent HPV vaccine approved for 27-45 age group
MDedge Internal Medicine
Outpatients antibiotics and disease codes
MDedge Internal Medicine
With more mindfulness, menopausal symptoms wane
MDedge Internal Medicine